PRINCETON, N.J., Oct. 20, 2005 (PRIMEZONE) -- The Bull Market Report (http://www.bullmarket.com), a long-term growth and income-generating focused online investment newsletter, announced today that it has provided subscribers with a detailed look at Altria's (NYSE:MO) earnings, and will provide reviews in today's issue for such companies as Allstate (NYSE:ALL), VeriSign (Nasdaq:VRSN), and Amgen (Nasdaq:AMGN).
All paid and trial subscribers to The Bull Market Report can now receive immediate access to The Bull Market Report's exclusive daily reports. As a trial or paid subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR51
In its earnings coverage, The Bull Market Report looked at the following topics, among many others:
-- What type of upside does the Bull Market Report see for Altria if the company splits up?
-- What does the Bull Market Report like about VeriSign's recent acquisition strategy?
-- Will Allstate be able to handle hurricane-related losses better in the future?
-- Why is Amgen better positioned today to meet high expectations than previously?
About The Bull Market Report:
Launched in 1997, The Bull Market Report has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The Bull Market Report's Recommended List includes over 50 companies across all major industries, including financials, healthcare, energy, technology, and retail, among others. As a testament to the durability of its value-focused and fundamentally sound recommendations in both up and down markets, The Bull Market Report is one of the oldest continuously published investment newsletters online. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR51
Subscribers also receive access to The Bull Market Report's special bonus reports, "Search Sector Outlook," "Biotech Sector Outlook," and "Understanding the Value of Insider Trading Data."
Note: This release was published by F.P. Real Ventures I, LLC (CRD #131926). Indie Research, LLC and the Bull Market editorial staff are not registered investment advisors, broker/dealers, or research analysts/organizations.